Goat is one of the major dairy and meat providers. In terms of structure, nutrient content, and medicinal properties, goat milk is somewhat different from other milk. The differences in composition are important in determining the technical suitability of goat milk and its products for health benefits. In recent years, there has been increasing attention to the identification and molecular composition of milk proteins and the interest in caprine milk. Casein, which accounts for almost 80% of all the proteins, is the most significant protein found in goat milk. It is a pioneer in the field of nutraceutical formulation and drug production by using the goat mammary gland as a bioreactor. In goat milk, the most prevalent proteins are αS‐casein, β‐casein, and κ‐casein. The aim of this review is to highlight the importance of goat milk casein and also focus on recent findings on their medicinal importance that may be helpful for further research on dairy products with health beneficial properties for humans as a remarkable nutraceutical. Practical applications Goat milk casein is considered as a healthy nutrient as well as a therapeutic agent to control abnormal or disease conditions through some of its biologically active peptide residues. Casein fractions of goat milk have been shown to exhibit different biologic activities. Therefore, this study aims to observe the use of goat milk in various disorders and to know about the different products made from goat milk. It will be helpful in the field of medicine to be a new active constituent for the management of various disease conditions.

Aim: Literature shows the traditional as well as scientific proven medicinal importance of Nyctanthes arbortristis Linn. In the it was aimed at to formulate and screen the antidiabetic, hypolipidemic and antioxidant properties of the tablets of arbortristoside-A obtained from N. arbortristis seeds. Materials and Methods: Arbortristoside-A was chemically isolated from the seeds' ethanolic extract of N. arbortristis. The antioxidant property of arbortristoside-A was screened in-vitro by the help of DPPH (2,2-diphenyl-1picrylhydrazyl) methodology. The granules of arbortristocide-A with suitable excipients were prepared by wet granulation method. The tablets were prepared by the help of rotating punch tablet machine and subjected to standard evaluation process. Its antidiabetic property was evaluated by using streptozotocin-induced diabetic wistar rats of either sex. This study also included a serum biochemical assays and pancreatic and hepatic histopathological modification. Results: Daily oral treatment with tablets of arbortristoside-A and glibenclamide (10 mg/kg) for three weeks reduced the plasma glucose, cholesterol, triglycerides, AST and ALT levels significantly whereas improvement in HDL-cholesterol level was observed (p<0.01) as that of the diabetic control animals. Significant recovery of the pancreas and liver was observed with the tablets administration which was supported by its significant antioxidant activity. Conclusion: Present results indicated that the tablets of arbortristoside-A have prominent effect in the overall management of diabetes mainly at its higher dose (75 mg/kg) in the diabetic due to its antilipidemic and antioxidant properties.